Safety and Efficacy of BAY 1817080, a P2X3 Receptor Antagonist, in Patients with Refractory Chronic Cough (RCC)
AH Morice, John A. Smith, Lorcan McGarvey, SS Birring, Sean Parker, Alice Turner, Isabella Gashaw, Lueder Fels, Stefan Klein, K. Francke, Christian Friedrich
Topics & Concepts
Refractory (planetary science)AntagonistChronic coughMedicineInternal medicineReceptor antagonistPharmacologyReceptorMaterials scienceMetallurgyAsthmaRespiratory and Cough-Related ResearchGastroesophageal reflux and treatmentsInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis